GXV-813 for schizophrenia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Mar 2026: Trial registered, NCT07467993
  2. 16 Mar 2026: Trial started, NCT07467993

The trials

NCT07467993: Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

State
Under way
Phase
Phase 2
People
142 planned
Started
16 Mar 2026
Primary completion
29 Jul 2027
Arms
GXV813
Results
None posted
  1. 12 Mar 2026: Trial registered
  2. 16 Mar 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.